BioCentury
ARTICLE | Clinical News

AGIL-AADC regulatory update

November 22, 2016 12:39 AM UTC

FDA granted rare pediatric disease designation to Agilis’ AGIL-AADC to treat Aromatic L-Amino Acid Decarboxylase (AADC) deficiency. The product is an adeno-associated viral (AAV) vector encoding the d...

BCIQ Company Profiles

Agilis Biotherapeutics Inc.